Fellowship · New Orleans, LA
Sponsored by Louisiana State University School of Medicine
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
The New England journal of medicine · 2025 · 227 citations · Meredith Clement
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
The New England journal of medicine · 2021 · 759 citations · Meredith Clement
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
The New England journal of medicine · 2022 · 396 citations · Michael Hagensee
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
Lancet (London, England) · 2025 · 74 citations · Stephanie Taylor
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
Lancet (London, England) · 2026 · 31 citations · Stephanie Taylor
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement.
JAMA network open · 2024 · 74 citations ·
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement.
JAMA network open · 2023 · 87 citations · Michelle Blyth
Diagnostic potential of exosomal extracellular vesicles in oncology.
BMC cancer · 2024 · 56 citations · Marco Ruiz